SequelSEC

Neuronetics, Inc. STIM

Surgical & Medical Instruments & Apparatus · CIK 0001227636 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$155.10M
Fiscal year ended 2026-06-30
Operating income
-$22.86M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$129.30MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$1.87Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.9×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity4.9×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Revenue YoY growth99.2%91th
Long-term debt / equity2.51x89th
R&D / revenue4.4%22th
Gross margin48.5%27th
Current ratio2.02x37th
SBC / revenue4.6%44th
Net margin-26.1%49th
Operating margin-21.1%49th

Neuronetics, Inc. (STIM) reported revenue of $155.10M and net income of -$30.43M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Neuronetics, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Neuronetics, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$155.10M
Cost of revenue$78.91M
Gross profit$76.19M
Operating income-$22.86M
Net income-$30.43M
Research & development$5.87M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$93.18M
General & administrative$48.87M
Selling & marketing$44.31M

Balance

Neuronetics, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$19.20M
Total assets$131.53M
Current assets$53.23M
Total liabilities$109.89M
Current liabilities$28.31M
Total equity incl. NCI$21.64M
Temporary (mezzanine) equityUnavailable
Inventory$5.50M
Accounts receivable$15.96M
Goodwill$23.62M
Long-term debt$61.52M
Accounts payable$12.42M

Cash flow

Neuronetics, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$10.33M
Capital expendituresUnavailable
Investing cash flow-$919.00K
Financing cash flow$18.70M
Net change in cashUnavailable
Stock-based compensation$5.96M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$2.41M

Derived

Neuronetics, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin49.1%
Operating margin-14.7%
FCF marginUnavailable
SBC / revenue3.8%
Current ratio1.88x
Revenue YoY growth39.6%
Net margin-19.6%
R&D / revenue3.8%
CapEx / revenueUnavailable
Long-term debt / equity2.84x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open STIM in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-11View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-03-17View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-06View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.